Table 8.
Summary of the prevalence of CMV detection of investigated cases and controls.
| Study | CMV-Positive Cases/Total | CMV-Positive Controls/Total | Statistically Significant? Y/N (p-Value) |
|---|---|---|---|
| Nakhaie, 2021 [163] | 8/49 (16%) | 1/49 (2%) § | Yes (p = 0.0307) |
| Costa, 2019 [165] | 49/49 (100%) for IE protein, 11/49 (22%) for LA protein |
2/26 (8%) § for IE protein 0/26 (0%) § for LA protein |
Yes (p = 0.0001) for IE protein, (p = 0.0126) for LA protein |
| Sepahvand, 2019 [166] | 20/37 (54%) | 10/35 (26%) * | Yes (p = 0.0340) |
| El Shazly, 2018 [167] | 11/61 (18%) | 1/20 (5%) * | No (p = 0.2765) |
| Bakhtiyrizadeh, 2017 [42] | 0/150 (0%) | 2/150 (1%) # | No (p = 0.4983) |
| Richardson, 2015 [142] | 0/70 (0%) | 2/70 (3%) § | No (p = 0.4964) |
* fibroadenomas, # unspecified benign lesions, § normal breast tissue from the same patient.